Anbio Biotechnology
For the period ended Apr 27, 2026. Filed Apr 27, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Apr 27, 2026 · Filed Apr 27, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Proxy Statement
Proxy Statement
The board of directors (the “Board”) of Anbio Biotechnology, a Cayman Islands exempted company (the “Company,” or “we”), is furnishing this Proxy Statement and the accompanying proxy card to you to solicit your proxy for a meeting of the holders of class A ordinary shares of a par value of $0.0001 each of the Company (the “Class A Ordinary Shares”) (the “Class A Meeting”) and an extraordinary general meeting of shareholders of the Company (the “EGM”). The Class A Meeting will be held on May 15, 2026 at 3 p.m., Germany Time (May 15, 2026 at 9 a.m., Eastern Time), at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany. The Meeting will be held immediately following the Class A Meeting, at Friedrich-Ebert-Anlage 35-37, 60327, Frankfurt am Main, Germany. The Class A Meeting and the EGM are collectively referred to as the “Meetings” and each a “Meeting”.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.